Cargando…

Solriamfetol impurities: Synthesis, characterization, and analytical method (UPLC-UV) validation

Given that impurities may affect the quality and safety of drug products, impurity identification and profiling is an integral part of drug quality control and is particularly important for newly developed medications such as solriamfetol, which is used to treat excessive daytime sleepiness. Althoug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Rifai, Nafisah, Alshishani, Anas, Darras, Fouad, Taha, Ola, Abu-Jalloud, Shereen, Shaghlil, Lena, Al-Ebini, Yousef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Xi'an Jiaotong University 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173169/ https://www.ncbi.nlm.nih.gov/pubmed/37181290 http://dx.doi.org/10.1016/j.jpha.2023.02.012

Ejemplares similares

Genome Similarities between Human-Derived and Mink-Derived SARS-CoV-2 Make Mink a Potential Reservoir of the Virus
por: Khalid, Mohammad, et al.
Publicado: (2022)

P148 Solriamfetol Titration & AdministRaTion (START): Dosing and titration strategies in patients with narcolepsy starting solriamfetol
por: Thorpy, M, et al.
Publicado: (2021)

Solriamfetol for the Use of Narcolepsy: A Systematic Review
por: Iturburu, Alisson, et al.
Publicado: (2022)

A randomized study of solriamfetol for excessive sleepiness in narcolepsy
por: Thorpy, Michael J., et al.
Publicado: (2019)

P147 Solriamfetol Titration & AdministRaTion (START): Characteristics of patients with obstructive sleep apnoea (OSA) and prescriber rationale for starting treatment with solriamfetol
por: Singh, H, et al.
Publicado: (2021)

Identification, synthesis and characterization of avanafil process impurities and determination by UPLC
por: Zhao, Mengmeng, et al.
Publicado: (2022)

Effects of solriamfetol on on‐the‐road driving in participants with narcolepsy: A randomised crossover trial
por: Vinckenbosch, Frederick, et al.
Publicado: (2022)

Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept Trial
por: Videnovic, Aleksandar, et al.
Publicado: (2021)

Pitolisant, a wake‐promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol
por: Krief, Stéphane, et al.
Publicado: (2021)

Effects of solriamfetol on on‐the‐road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea
por: Vinckenbosch, Frederick, et al.
Publicado: (2022)

An Automatic Immunoaffinity Pretreatment of Deoxynivalenol Coupled with UPLC-UV Analysis
por: Liu, Hongmei, et al.
Publicado: (2022)

Exploiting the power of UPLC in separation and simultaneous determination of pholcodine, guaiacol along with three specified guaiacol impurities
por: Mohamed, Hager M., et al.
Publicado: (2023)

Effects of Solriamfetol on Quality-of-Life Measures from a 12-Week Phase 3 Randomized Controlled Trial
por: Weaver, Terri E., et al.
Publicado: (2020)

Randomized Controlled Trial of Solriamfetol for Excessive Daytime Sleepiness in OSA: An Analysis of Subgroups Adherent or Nonadherent to OSA Treatment
por: Schweitzer, Paula K., et al.
Publicado: (2021)

Analysis of phenolic compounds in Matricaria chamomilla and its extracts by UPLC-UV
por: Haghi, G., et al.
Publicado: (2014)

Geographical distribution of host's specific SARS-CoV-2 mutations in the early phase of the COVID-19 pandemic
por: Khalid, Mohammad, et al.
Publicado: (2023)

Comparative Study of Augmented Classical Least Squares Models for UV Assay of Co-Formulated Antiemetics Together with Related Impurities
por: Al-Saleem, Muneera S. M., et al.
Publicado: (2023)

Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives
por: Abad, Vivien C
Publicado: (2021)

Analytical Method Development for 19 Alkyl Halides as Potential Genotoxic Impurities by Analytical Quality by Design
por: Lee, Kyoungmin, et al.
Publicado: (2022)

Novel Validated Stability-Indicating UPLC Method for the Estimation of Naproxen and its Impurities in Bulk Drugs and Pharmaceutical Dosage Form
por: Venkatarao, Papanaboina, et al.
Publicado: (2012)

Development and Validation of a Stability-Indicating RP-UPLC Method for the Estimation of Impurities in Cinacalcet Hydrochloride API and its Formulation
por: Sunil Reddy, Pingili, et al.
Publicado: (2015)

Structural Elucidation of Alkali Degradation Impurities of Favipiravir from the Oral Suspension: UPLC-TQ-ESI-MS/MS and NMR
por: Patel, Ravi, et al.
Publicado: (2022)

Quantitative Determination of Four Potential Genotoxic Impurities in the Active Pharmaceutical Ingredients in TSD-1 Using UPLC-MS/MS
por: Wang, Taiyu, et al.
Publicado: (2022)

Single‐Dose Pharmacokinetics and Safety of Solriamfetol in Participants With Normal or Impaired Renal Function and With End‐Stage Renal Disease Requiring Hemodialysis
por: Zomorodi, Katie, et al.
Publicado: (2019)

A Novel, Validated Stability-Indicating UPLC Method for the Estimation of Lansoprazole and its Impurities in Bulk Drug and Pharmaceutical Dosage Forms
por: Rao, Papanaboina Venkata, et al.
Publicado: (2013)

Identification, synthesis and characterization of process related impurities of benidipine hydrochloride, stress-testing/stability studies and HPLC/UPLC method validations()
por: Bellur Atici, Esen, et al.
Publicado: (2015)

AQbD based green UPLC method to determine mycophenolate mofetil impurities and Identification of degradation products by QToF LCMS
por: Muchakayala, Siva Krishna, et al.
Publicado: (2022)

Greenness assessment of UPLC/MS/MS method for determination of two antihypertensive agents and their harmful impurities with ADME/TOX profile study
por: Nagieb, Hend M., et al.
Publicado: (2023)

Using UPLC-LTQ-Orbitrap-MS and HPLC-CAD to Identify Impurities in Cycloastragenol, Which Is a Pre-Clinical Candidate for COPD
por: Zhu, Feng, et al.
Publicado: (2023)

Impure Water Makes Impure Ice
Publicado: (1882)

Comparative study of adsorptive role of carbonaceous materials in removal of UV-active impurities of paclitaxel extracts()
por: Nasiri, Jaber, et al.
Publicado: (2015)

A Practical Quality Control Method for Saponins Without UV Absorption by UPLC-QDA
por: Zhao, Manjia, et al.
Publicado: (2018)

A Simple and Rapid UPLC‐UV Method for Detecting DPD Deficiency in Patients With Cancer
por: Marin, Clémence, et al.
Publicado: (2020)

Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea
por: Malhotra, Atul, et al.
Publicado: (2019)

Solriamfetol Titration and AdministRaTion (START) in Patients with Obstructive Sleep Apnea: A Retrospective Chart Review and Hypothetical Patient Scenario
por: Singh, Haramandeep, et al.
Publicado: (2022)

A Novel, Rapid, and Validated Stability-Indicating UPLC Method for the Estimation of Drotaverine Hydrochloride and Ibuprofen Impurities in Oral Solid Dosage Form
por: Vijay Kumar, Rekulapally, et al.
Publicado: (2015)

Stability-indicating HPLC-DAD/UV-ESI/MS impurity profiling of the anti-malarial drug lumefantrine
por: Verbeken, Mathieu, et al.
Publicado: (2011)

A Randomized, Double‐Blind, Placebo‐ and Positive‐Controlled, 4‐Period Crossover Study of the Effects of Solriamfetol on QTcF Intervals in Healthy Participants
por: Zomorodi, Katie, et al.
Publicado: (2020)

Taxifolin stability: In silico prediction and in vitro degradation with HPLC-UV/UPLC–ESI-MS monitoring
por: Stenger Moura, Fernanda Cristina, et al.
Publicado: (2021)

Analytical Chemistry of Impurities in Amino Acids Used as Nutrients: Recommendations for Regulatory Risk Management
por: Karakawa, Sachise, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7k8e3lkvbv7sf0q5up898hvjjk